Abstract:Background: Obesity-induced glucose metabolism disorder is associated with chronic, low-grade, systemic inflammation and is considered a risk factor for diabetes and metabolic syndrome. Resveratrol (RES), a natural anti-inflammatory compound, is observed to improve glucose tolerance and insulin sensitivity in obese rodents and humans. This study aimed to test the effects of RES administration on insulin signaling and the inflammatory response in visceral white adipose tissue (WAT) caused by a high-fat diet (HFD) in mice. Methods: A total of 40 wild-type C57BL/6 male mice were divided into four groups (10 in each group): the standard chow diet (STD) group was fed a STD; the HFD group was fed a HFD; and the HFD-RES/L and HFD-RES/H groups were fed a HFD plus RES (200 and 400 mg/kg/day, respectively). The L and H in RES/L and RES/H stand for low and high, respectively. Glucose tolerance, insulin sensitivity, circulating inflammatory biomarkers and lipid profile were determined. Quantitative PCR and Western blot were used to determine the expression of CC-chemokine receptor 2 (CCR2), other inflammation markers, glucose transporter 4 (GLUT4), insulin receptor substrate 1 (IRS-1) and pAkt/Akt and to assess targets of interest involving glucose metabolism and inflammation in visceral WAT. Results: HFD increased the levels of total cholesterol, triglycerides, low-density lipoprotein cholesterol and proinflammatory cytokines in serum, decreased the high-density lipoprotein cholesterol level in serum, and induced insulin resistance and WAT inflammation in mice. However, RES treatment alleviated insulin resistance, increased the expressions of pAkt, GFUT4 and IRS-1 in WAT, and decreased serum proinflammatory cytokine levels, macrophage infiltration and CCR2 expression in WAT. Conclusion: Our results indicated that WAT CCR2 may play a vital role in macrophage infiltration and the inflammatory response during the development of insulin resistance in HFD-induced obesity. These data suggested that administration of RES offers protection against abnormal glucose metabolism and inflammatory adaptations in visceral WAT in mice with HFD-induced obesity.

Effects of Resveratrol on Adipocytes: Evidence from In Vitro and In Vivo Studies

Resveratrol and Its Human Metabolites—Effects on Metabolic Health and Obesity

The Beneficial Effects of Quercetin, Curcumin, and Resveratrol in Obesity

Effects of resveratrol on the anthropometric indices and inflammatory markers: an umbrella meta-analysis

Novel strategies for preventing diabetes and obesity complications with natural polyphenols

Resveratrol and Its Derivatives Diminish Lipid Accumulation in Adipocytes In Vitro—Mechanism of Action and Structure–Activity Relationship

Effects of Resveratrol on Gut Microbiota and Fat Storage in A Mouse Model with High-Fat-Induced Obesity

Effect of resveratrol on insulin action in primary myotubes from lean individuals and individuals with severe obesity

Anti-Obesity Effects of Polyphenol Intake: Current Status and Future Possibilities

The therapeutic potential of resveratrol: a review of clinical trials

Resveratrol inhibits white adipose deposition by the ESR1-mediated PI3K/AKT signaling pathway

The Role of Resveratrol Administration in Human Obesity

Antiobesity molecular mechanisms of action: Resveratrol and pterostilbene

Do the Effects of Resveratrol on Thermogenic and Oxidative Capacities in IBAT and Skeletal Muscle Depend on Feeding Conditions?

Red Oranges and Olive Leaf Waste-Derived Bioactive Extracts Promote Adipocyte Functionality In Vitro

Browning of Adipocytes: A Potential Therapeutic Approach to Obesity

Resveratrol Inhibits the Formation and Accumulation of Lipid Droplets Through AdipoQ Signal Pathway and Lipid Metabolism Lncrnas

Resveratrol exerts anti-obesity effects while browning the inguinal white adipose tissue

Dihydro-Resveratrol Attenuates Oxidative Stress, Adipogenesis and Insulin Resistance in In Vitro Models and High-Fat Diet-Induced Mouse Model via AMPK Activation

Resveratrol stimulates brown of white adipose via regulating ERK/DRP1-mediated mitochondrial fission and improves systemic glucose homeostasis

Resveratrol reduces the inflammatory response in adipose tissue and improves adipose insulin signaling in high-fat diet-fed mice.